Market Cap 992.93M
Revenue (ttm) 419.81M
Net Income (ttm) -58.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 217.76
Profit Margin -13.94%
Debt to Equity Ratio 0.00
Volume 327,700
Avg Vol 1,136,048
Day's Range N/A - N/A
Shares Out 60.29M
Stochastic %K 59%
Beta 0.64
Analysts Strong Sell
Price Target $30.12

Company Profile

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and...

Industry: Health Information Services
Sector: Healthcare
Phone: 888 654 7473
Address:
1521 Concord Pike, Suite 301 PMB 221, Wilmington, United States
GenericPoster
GenericPoster Dec. 23 at 1:58 PM
$PHR Bullish article but behind a paywall. This is probably why PHR is up over $-.50 in pre-market trading on 5,300 shares. Note that the analysts still have price targets over $30 on PHR and the market is starting to boarden out so PHR just needs to get over any tax loss harvesting/selling to year end which could present a good buying opportunity. From: https://finance.yahoo.com/m/e0365481-2f52-3f05-abf2-c12559a89d9b/phreesia-stock-has-been.html
0 · Reply
Invest2live
Invest2live Dec. 19 at 4:22 PM
$B 168% already; congrats 🎈 🌿🎈 Follow for more research base stock alerts Check out $NGD and $PHR; undervalued now.
2 · Reply
Invest2live
Invest2live Dec. 16 at 7:36 PM
$PHR it can go to $50+ IF you are patient and long. This has potential. do your DD and get in.
1 · Reply
JarvisFlow
JarvisFlow Dec. 16 at 2:16 PM
Barclays has adjusted their stance on Phreesia ( $PHR ), setting the rating to Overweight with a target price of 26 → 24.
0 · Reply
MacroTorchX_1499
MacroTorchX_1499 Dec. 16 at 12:42 PM
$PHR health tech small cap, coiling under resistance, watch for trend confirmation on a high-volume breakout
0 · Reply
Invest2live
Invest2live Dec. 15 at 2:57 PM
$TSLA 210% already; congrats 🎈 🎊🎉 Checkout $TTD and $PHR
0 · Reply
Invest2live
Invest2live Dec. 15 at 2:53 PM
$HRMY 37% already; congrats 🎉 🎊🎈 Checkout $PHR and $TTD; undervalued now.
0 · Reply
swingsanctuary
swingsanctuary Dec. 13 at 4:52 PM
$PHR we will go back up to 17.5 Glitches for the win Since 11/4 there have been 93 glitches 52 have hit within 0-2 trading days 11 have hit within 3-6 trading days 3 have hit within 7-14 trading days 1 hit >14 days 26 are open (14 of those within the last three days) Free 7 day trial come and see glitch prices Use code wintersale for 50% off 3 months
0 · Reply
freddycan
freddycan Dec. 12 at 6:26 PM
$PHR according to analyst still an expensive stock trading at 333 pe
1 · Reply
GenericPoster
GenericPoster Dec. 12 at 2:32 PM
$PHR I added over the past two days and will continue to add on weakness. See below screenshots showing where analyst EPS estimates have increased substantially; more than just the addition of AccessOne. See where the revenue growth is still very good at 15% or so over the next year or so; again more than just the addition of AccessOne and read the conference call notes to see their increases in customers/users and increasing average spend by customers. Finally, see how analysts have reiterated their outperform rating with price targets nearly double the current share price. PHR is thinly traded and seemingly easy to manipulate (take down after good earnings). But, as money diversifies from AI, some of it should find its way to PHR
0 · Reply
Latest News on PHR
Phreesia: Profitable At Last, Priced Like It Isn't

Dec 22, 2025, 7:07 AM EST - 2 days ago

Phreesia: Profitable At Last, Priced Like It Isn't


Phreesia, Inc. (PHR) Q3 2026 Earnings Call Transcript

Dec 8, 2025, 7:37 PM EST - 16 days ago

Phreesia, Inc. (PHR) Q3 2026 Earnings Call Transcript


Phreesia's Megan Turco Named to MM+M 40 Under 40

Dec 4, 2025, 4:05 PM EST - 20 days ago

Phreesia's Megan Turco Named to MM+M 40 Under 40


Phreesia Named to the 2025 Deloitte Technology Fast 500™

Nov 19, 2025, 4:05 PM EST - 5 weeks ago

Phreesia Named to the 2025 Deloitte Technology Fast 500™


Holding Phreesia Despite Initial Post-Earnings Disappointment

Sep 12, 2025, 8:51 AM EDT - 3 months ago

Holding Phreesia Despite Initial Post-Earnings Disappointment


Phreesia Analysts Raise Their Forecasts After Q2 Results

Sep 5, 2025, 3:07 PM EDT - 3 months ago

Phreesia Analysts Raise Their Forecasts After Q2 Results


Phreesia, Inc. (PHR) Q2 2026 Earnings Call Transcript

Sep 4, 2025, 7:42 PM EDT - 3 months ago

Phreesia, Inc. (PHR) Q2 2026 Earnings Call Transcript


Phreesia Announces Second Quarter Fiscal 2026 Results

Sep 4, 2025, 4:05 PM EDT - 3 months ago

Phreesia Announces Second Quarter Fiscal 2026 Results


Why Phreesia Feels Like The Right Bet In Healthcare Tech

Aug 18, 2025, 7:18 AM EDT - 4 months ago

Why Phreesia Feels Like The Right Bet In Healthcare Tech


Phreesia, Inc. (PHR) Q1 2026 Earnings Call Transcript

May 28, 2025, 10:46 AM EDT - 7 months ago

Phreesia, Inc. (PHR) Q1 2026 Earnings Call Transcript


Phreesia Announces First Quarter Fiscal 2026 Results

May 28, 2025, 7:03 AM EDT - 7 months ago

Phreesia Announces First Quarter Fiscal 2026 Results


Phreesia Sets Release Date for Fiscal First Quarter 2026 Results

Apr 29, 2025, 6:40 AM EDT - 8 months ago

Phreesia Sets Release Date for Fiscal First Quarter 2026 Results


Phreesia Maintains Its Momentum

Mar 16, 2025, 9:00 AM EDT - 10 months ago

Phreesia Maintains Its Momentum


Phreesia, Inc. (PHR) Q4 2025 Earnings Call Transcript

Mar 12, 2025, 8:30 PM EDT - 10 months ago

Phreesia, Inc. (PHR) Q4 2025 Earnings Call Transcript


Phreesia Announces Fourth Quarter Fiscal 2025 Results

Mar 12, 2025, 4:03 PM EDT - 10 months ago

Phreesia Announces Fourth Quarter Fiscal 2025 Results


Phreesia's Sally Thayer Selected as a Top Woman Leader in Software

Feb 11, 2025, 6:48 AM EST - 11 months ago

Phreesia's Sally Thayer Selected as a Top Woman Leader in Software


Phreesia Has Turned The Corner, Can It Continue To Mend?

Dec 12, 2024, 6:44 AM EST - 1 year ago

Phreesia Has Turned The Corner, Can It Continue To Mend?


Phreesia, Inc. (PHR) Q3 2025 Earnings Call Transcript

Dec 9, 2024, 7:22 PM EST - 1 year ago

Phreesia, Inc. (PHR) Q3 2025 Earnings Call Transcript


Phreesia Announces Third Quarter Fiscal 2025 Results

Dec 9, 2024, 4:05 PM EST - 1 year ago

Phreesia Announces Third Quarter Fiscal 2025 Results


Phreesia: Remain Bullish Given The Healthy Growth Outlook

Sep 5, 2024, 12:19 PM EDT - 1 year ago

Phreesia: Remain Bullish Given The Healthy Growth Outlook


Phreesia, Inc. (PHR) Q2 2025 Earnings Call Transcript

Sep 4, 2024, 8:08 PM EDT - 1 year ago

Phreesia, Inc. (PHR) Q2 2025 Earnings Call Transcript


Phreesia Announces Second Quarter Fiscal 2025 Results

Sep 4, 2024, 4:03 PM EDT - 1 year ago

Phreesia Announces Second Quarter Fiscal 2025 Results


GenericPoster
GenericPoster Dec. 23 at 1:58 PM
$PHR Bullish article but behind a paywall. This is probably why PHR is up over $-.50 in pre-market trading on 5,300 shares. Note that the analysts still have price targets over $30 on PHR and the market is starting to boarden out so PHR just needs to get over any tax loss harvesting/selling to year end which could present a good buying opportunity. From: https://finance.yahoo.com/m/e0365481-2f52-3f05-abf2-c12559a89d9b/phreesia-stock-has-been.html
0 · Reply
Invest2live
Invest2live Dec. 19 at 4:22 PM
$B 168% already; congrats 🎈 🌿🎈 Follow for more research base stock alerts Check out $NGD and $PHR; undervalued now.
2 · Reply
Invest2live
Invest2live Dec. 16 at 7:36 PM
$PHR it can go to $50+ IF you are patient and long. This has potential. do your DD and get in.
1 · Reply
JarvisFlow
JarvisFlow Dec. 16 at 2:16 PM
Barclays has adjusted their stance on Phreesia ( $PHR ), setting the rating to Overweight with a target price of 26 → 24.
0 · Reply
MacroTorchX_1499
MacroTorchX_1499 Dec. 16 at 12:42 PM
$PHR health tech small cap, coiling under resistance, watch for trend confirmation on a high-volume breakout
0 · Reply
Invest2live
Invest2live Dec. 15 at 2:57 PM
$TSLA 210% already; congrats 🎈 🎊🎉 Checkout $TTD and $PHR
0 · Reply
Invest2live
Invest2live Dec. 15 at 2:53 PM
$HRMY 37% already; congrats 🎉 🎊🎈 Checkout $PHR and $TTD; undervalued now.
0 · Reply
swingsanctuary
swingsanctuary Dec. 13 at 4:52 PM
$PHR we will go back up to 17.5 Glitches for the win Since 11/4 there have been 93 glitches 52 have hit within 0-2 trading days 11 have hit within 3-6 trading days 3 have hit within 7-14 trading days 1 hit >14 days 26 are open (14 of those within the last three days) Free 7 day trial come and see glitch prices Use code wintersale for 50% off 3 months
0 · Reply
freddycan
freddycan Dec. 12 at 6:26 PM
$PHR according to analyst still an expensive stock trading at 333 pe
1 · Reply
GenericPoster
GenericPoster Dec. 12 at 2:32 PM
$PHR I added over the past two days and will continue to add on weakness. See below screenshots showing where analyst EPS estimates have increased substantially; more than just the addition of AccessOne. See where the revenue growth is still very good at 15% or so over the next year or so; again more than just the addition of AccessOne and read the conference call notes to see their increases in customers/users and increasing average spend by customers. Finally, see how analysts have reiterated their outperform rating with price targets nearly double the current share price. PHR is thinly traded and seemingly easy to manipulate (take down after good earnings). But, as money diversifies from AI, some of it should find its way to PHR
0 · Reply
RunnerSignals
RunnerSignals Dec. 12 at 12:14 PM
Oversold bounce alert! $SE $VG $VEEV $PHR $DOMO showing early rebound signs off lows is this the start of a quick snapback? https://stocksrunner.com/news/2025-12-12-oversold-stocks-to-watch
0 · Reply
SwiftBulls14
SwiftBulls14 Dec. 11 at 5:13 PM
$PHR healthcare IT, sticky recurring revenue that institutions like once they trust the growth path
0 · Reply
RunnerSignals
RunnerSignals Dec. 11 at 4:52 AM
RSI Alert Pro subscribers only ​$MSFT $TMUS $VG $PHR $STNG are oversold and flashing potential bounces see which setups could pay off next in our full analysis https://stocksrunner.com/news/2025-12-10-rsi-alert-stocks-in-oversold-territory-with-potential-near-term-bounce
0 · Reply
DipNuke
DipNuke Dec. 10 at 11:40 PM
0 · Reply
DanVbarrons
DanVbarrons Dec. 10 at 9:56 PM
$PHR Brutal price action down 40% in last 3 months. Here's the situation with Phreesia.. 18 Wall Street analysts (an this lowly reporter) with a buy rating and avg. price target implying +100% upside all got it wrong. Market (unfortunately) decided this meditech innovator needed to be re-rated as just another B2B software name. Maybe its a value story now following crash??
0 · Reply
RunnerSignals
RunnerSignals Dec. 10 at 8:31 PM
1/4 Stock Upgrades Today $ALLR $OSTX $SNTI $PHR $RAPP Biotech bonanza incoming sky-high upside alert buckle up for gains https://stocksrunner.com/news/2025-12-10-stock-upgrades-today-show-top-picks
0 · Reply
graceevans_66
graceevans_66 Dec. 10 at 5:50 PM
$PHR small cap health tech, if it clears the coil with volume that is your confirm
0 · Reply
DipNuke
DipNuke Dec. 10 at 4:28 PM
$PHR massively oversold - bought on the bell! 🚀
0 · Reply
PencilNeckGeek
PencilNeckGeek Dec. 10 at 2:49 PM
$PHR Nice recovery. Glad I bought yesterday. Let's go 🚀🚀🚀
0 · Reply
JarvisFlow
JarvisFlow Dec. 10 at 2:34 PM
Mizuho updates rating for Phreesia ( $PHR ) to Outperform, target set at 36 → 28.
0 · Reply
JarvisFlow
JarvisFlow Dec. 10 at 12:51 PM
Baird updates rating for Phreesia ( $PHR ) to Outperform, target set at 31 → 25.
0 · Reply
Prathik567
Prathik567 Dec. 10 at 4:17 AM
$PHR this will go up to 18$ by eoy
0 · Reply